(CNN) -- A pill has cut the risk of hospitalization or death from COVID-19 by half in a study, Merck and Ridgeback Biotherapeutics said Friday. It would become the first oral medicine that fights viral infection for COVID-19 if approved by the FDA for emergency use authorization.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
